Concepedia

Michele Pellegrini

MP

21

Publications

1.5K

Citations

15

H-Index

2001

Active since

Affiliations

Novartis (Italy)(Current)

Novartis (Germany)

Toscana Life Sciences

Novartis (Switzerland)

Nova Medical (United States)

Michele Pellegrini is an author at Novartis (Italy) specializing in medicine, immunology, and vaccination.

ORCID

Top concepts

Publications per year

2001–2024

21

Publications

21

Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease

Alberto Priori, Guglielmo Foffani, A. Pesenti et al. · Experimental Neurology · 2004 · 514 citations

, , +8

Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant

Timo Vesikari, Michele Pellegrini, Aino Karvonen et al. · The Pediatric Infectious Disease Journal · 2009 · 190 citations

MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database

Michele Pellegrini, Uwe Nicolay, Kelly Lindert et al. · Vaccine · 2009 · 183 citations

, , +10

MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination

Timo Vesikari, Nicola Groth, Aino Karvonen et al. · Vaccine · 2009 · 129 citations

, , +9

Effect of Sulfhydryl and non-Sulfhydryl Angiotensin-Converting Enzyme Inhibitors on Endothelial Function in Essential Hypertensive Patients

Anna Maria Fratta Pasini, Ulisse Garbin, M.C. Nava et al. · American Journal of Hypertension · 2007 · 68 citations · Full text

Rows per page

1–5 of 21